Ethambutol (E)
Sponsors
University of Oxford, Michael Hoelscher, University College, London, Shenzhen Third People's Hospital, Shanghai Pulmonary Hospital, Shanghai, China
Conditions
Drug-Susceptible Pulmonary TuberculosisMycobacterium Avium Complex Pulmonary DiseaseOther Specified Pulmonary TuberculosisPulmonary TuberculosisTuberculosisTuberculosis (TB)Tuberculosis, Pulmonary
Phase 1
Phase 2
PanACEA - STEP2C -01
RecruitingNCT05807399
Start: 2023-04-14End: 2027-12-30Target: 390Updated: 2025-10-07
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
RecruitingNCT06114628
Start: 2024-01-09End: 2027-08-11Target: 2500Updated: 2025-10-06
Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis
Not yet recruitingNCT07129629
Start: 2025-08-20End: 2027-12-31Target: 45Updated: 2025-08-19
Phase 3
A PAN-USR TB Multi-Center Trial
RecruitingNCT06905522
Start: 2025-06-18End: 2029-12-31Target: 610Updated: 2025-12-01
Ultra-Short Regimen for Elderly DS-TB
Not yet recruitingNCT07076225
Start: 2025-07-25End: 2030-07-31Target: 300Updated: 2025-07-22
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)
Not yet recruitingNCT07163143
Start: 2025-11-30End: 2029-04-30Target: 784Updated: 2025-09-09